51 results
8-K
EX-99.1
MRZM
Marizyme, Inc.
25 Feb 20
Departure of Directors or Certain Officers
1:17pm
all business and R&D efforts at iDrug Delivery Inc. as President and CEO since December 2017. He continues to serve as executive and board advisor
8-K
MRZM
Marizyme, Inc.
26 Feb 21
Departure of Directors or Certain Officers
5:00pm
and Chairman of R&D Future Aire Tech (2011 – 2013), President and Chairman of Neuron Biotech (2007 – 2013, and President and Chairman of Synerx Pharmaceutical
8-K
MRZM
Marizyme, Inc.
26 Apr 10
Entry into a Material Definitive Agreement
12:00am
.
Provides a mechanism for internal marketing or R&D and feedback.
Allows for employee self-service support.
Reduces communications costs.
Key Features
8-K/A
MRZM
Marizyme, Inc.
7 May 10
Entry into a Material Definitive Agreement
12:00am
of the interactions.
Provides a mechanism for internal marketing or R&D and feedback.
Allows for employee self-service support.
Reduces communications costs
8-K
EX-10.1
rnc17a4lzbl zz2zz
26 Apr 10
Entry into a Material Definitive Agreement
12:00am
SC 14F1
pkl7 4iaz6
15 Apr 10
Statement regarding change in majority of directors
12:00am